Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LDK378 in ROS1-positive NSCLC
NCT03399487Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Jul 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ceritinib in non-small cell lung cancer (NSCLC), sponsored by Yonsei University. Status: unknown.
02
Drugs
ceritinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03399487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03399487.